Interview - Tom Yarema, M.D. on Covid-19 and Ivermectin

Listen Now to Dr. Tom 1.26.2021

It looks like we have some good news on the virus front. It appears that the common drug, Ivermectin,  an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2). Dr. Tom brings us up to date on the use of the drug clinically for Covid-19.  

From post-graduate work in Emergency Rooms across the nation to international Foreign Relief work, to working with Traditional Indigenous healers in rain-forests of Central America, Dr. Tom has followed his passion of bringing the best of all systems of medicine together.  He uses his knowledge of Western, Eastern and Ayurvedic modalities to create results-driven solutions to heal the chronic pain and illnesses of his patients…